Medifocus Inc MDFZF

Healthcare Biotechnology

Medifocus Inc develops and sells minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostate Hyperplasia (BHP). It owns two focused heat technology platforms, The Endo-thermotherapy Platform-from which Prolieve was developed, can be used to treat cancers in prostate, rectal, cervical and esophageal, and The Adaptive Phased Array Microwave Focusing Platform which directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The company through its operations generates revenue from the United States.

EXPM:MDFZF - Post by User

Medifocus Inc

Bullboard Posts

Post by MichaelD1on Oct 01, 2011 2:07pm

230 Views

Post# 19107732

Vote on new control person & financing

From the latest Management Information Circular posted on www.sedar.com on 9/30:

https://www.sedar.com/GetFile.do?lang=EN&docClass=10&issuerNo=00023463&fileName=/csfsprod/data123/filings/01808185/00000001/s%3A%5CFILINGS%5CMedifocus%5C2011-AGM%5CCircular.pdf

"BE IT RESOLVED as an ordinary resolution that:

1. the creation of a new Control Person which may result from the planned private placement of up to $10,000,000 in the aggregate, be and is hereby approved;

2. the private placement resulting in the creation of the new Control Person"

My understanding is this will be voted on at the October 20th meeting, and the impact should be very material for the company.

GLTA,

Michael D.

Bullboard Posts

Global Tungsten Market and Supply Security